Macin Remedies India Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 24-10-2024
- Paid Up Capital ₹ 0.50 M
as on 24-10-2024
- Company Age 12 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 5.93 Cr
as on 24-10-2024
- Revenue -3.28%
(FY 2023)
- Profit -30.03%
(FY 2023)
- Ebitda 58.18%
(FY 2023)
- Net Worth 50.04%
(FY 2023)
- Total Assets 23.92%
(FY 2023)
About Macin Remedies India
The Corporate was formerly known as Macin Remedies Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹5.93 Cr.
Avtar Saggu, Baljeet Kaur, Parveen, and One other member serve as directors at the Company.
- CIN/LLPIN
U24232PB2012PLC036218
- Company No.
036218
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
07 May 2012
- Date of AGM
30 Nov 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Moga, Punjab, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Macin Remedies India Limited offer?
Macin Remedies India Limited offers a wide range of products and services, including Antibiotic Injection, Gentamicin Injection, Diclofenac, Diclofenac Sodium Injection, Vitamin & Multivitamin Injections, Multivitamin Injection, Ampicillin Injection, Meropenem Injection, Ceftriaxone Injection, Gastrointestinal Drugs.
Who are the key members and board of directors at Macin Remedies India?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Avtar Saggu  | Director | 28-Sep-2012 | Current |
| Baljeet Kaur | Director | 07-May-2012 | Current |
| Parveen | Director | 01-Mar-2021 | Current |
| Pramod Singh | Director | 01-Feb-2023 | Current |
Financial Performance of Macin Remedies India.
Macin Remedies India Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 3.28% decrease. The company also saw a substantial fall in profitability, with a 30.03% decrease in profit. The company's net worth Soared by an impressive increase of 50.04%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Macin Remedies India?
In 2023, Macin Remedies India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Dr Mendeleev Research And Formulation LimitedActive 6 years 9 daysAvtar Saggu, Baljeet Kaur and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 28 Aug 2021 | ₹5.53 Cr | Open |
Others Creation Date: 20 Mar 2017 | ₹4.00 M | Open |
How Many Employees Work at Macin Remedies India?
Unlock and access historical data on people associated with Macin Remedies India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Macin Remedies India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Macin Remedies India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
